DoD Peer Reviewed Cancer, Idea Award | W81XWH 21 PRCRP IA

Opportunity Information: Apply for W81XWH 21 PRCRP IA

The DoD Peer Reviewed Cancer Research Program (PRCRP) Idea Award (FY21) is a Department of Defense funding opportunity designed to spark bold, early-stage cancer research ideas that have not yet been proven but could lead to major breakthroughs if they work. It is aimed at high-risk, potentially high-reward concepts, including new theories, paradigms, tools, or methods that could change how cancer is understood, prevented, detected, or treated. A central requirement is that the proposed work be clearly relevant to military health, meaning it should matter for active-duty Service Members, Veterans, other military beneficiaries, and the broader American public. The program places special importance on cancers or cancer-risk circumstances that affect the Service Member support system, including military families, reflecting the reality that health challenges ripple through readiness, caregiving, and long-term well-being.

A defining feature of the Idea Award is that it is not meant to fund the next obvious step of an existing research line. The program is explicitly looking for innovation rather than incremental progress. Projects that simply extend established work, make routine refinements, follow a predictable progression, or swap one cancer type or model system for another without a genuinely new angle are not considered competitive under this mechanism. Instead, the strongest applications are expected to introduce something genuinely creative, such as challenging prevailing assumptions, reframing a longstanding problem from a new perspective, or proposing a novel approach that could open up an entirely different direction for the field.

Even though the award supports exploratory science, the research plan still needs to be rigorous. Applicants are expected to present a well-formulated, testable hypothesis backed by a strong scientific rationale and a sound study design. The emphasis is on credible experimental logic and a clear plan for generating interpretable results, even if the underlying concept is untested. In other words, the idea can be risky, but the way it is tested should be careful and methodologically solid.

Preliminary data are not required, and the program signals that this award is not intended to underwrite ongoing work already underway in the applicant's laboratory. Including extensive preliminary data (beyond truly serendipitous findings) can be at odds with the exploratory intent, though applicants may include data if they choose; if they do, it will be reviewed and evaluated as part of the application. Researchers who already have strong preliminary evidence and are ready for a more direct next step toward patient impact are steered toward a different mechanism, the FY21 PRCRP Impact Award, which better fits projects that are more mature and closer to outcomes.

The expected product of an Idea Award project is not a finished clinical solution, but the creation of robust preliminary data and foundational insights that can justify and power future, larger research efforts. This could include early evidence about mechanisms of cancer initiation or progression, new ways to think about cancer risk in military-relevant contexts, or exploratory work related to quality of life during and after cancer treatment. In short, the award is meant to plant the seeds for future advances by funding the kind of unconventional, forward-looking science that might be too early or too uncertain for other funding sources, while still keeping the Military Health System and DoD health priorities clearly in view.

Administratively, this opportunity was offered by the Department of Defense (Department of the Army, USAMRAA) under Funding Opportunity Number W81XWH-21-PRCRP-IA, with support provided through grants and/or cooperative agreements in the science and technology research and development category (CFDA 12.420). Eligibility was listed as unrestricted, meaning a wide range of applicant entity types could apply as long as they met any requirements stated in the full announcement. The opportunity was posted March 24, 2021, had an original closing date of September 8, 2021, and anticipated making around 25 awards. The public listing did not specify a fixed award ceiling amount.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Peer Reviewed Cancer, Idea Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 24, 2021.
• Applicants must submit their applications by Sep 08, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 25 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 PRCRP IA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: